Akari Therapeutics Plc research brief

CIK 1541157 Copy CIK

Generated Nov. 3, 2026, 6:14 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: TAMPA FL. Reported legal jurisdiction: UNITED KINGDOM. These do not establish investor residence or where funds were deployed.

• June 3, 2026 · D · 0001493152-26-027117 · Source evidence

  Reported offering amount: 5500000 USD. Reported amount sold: 1833333 USD.

• Oct. 24, 2025 · D · 0001493152-25-019187 · Source evidence

  Reported offering amount: 6250000 USD. Reported amount sold: 6250000 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Akari Therapeutics Plc research brief,” CIK 1541157, retrieved Nov. 3, 2026, 6:14 a.m.. Cite the specific accessions used. No amounts have been summed.